Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.07.24	Beware, Wegovy -- Pfizer Is Working on a Competitor (MotleyFool)
24.07.24	Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study (Benzinga)
24.07.24	This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer (MotleyFool)
24.07.24	Pfizer announces positive results from late-stage trial of hemophilia A treatment (MarketWatch)
24.07.24	Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidate (Businesswire)
24.07.24	GSK, Pfizer and Moderna face RSV vaccine sales slump (Financial Times)
23.07.24	Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial (Benzinga)
22.07.24	Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche (MotleyFool)
20.07.24	Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It. (MotleyFool)
18.07.24	Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology Portfolio (Benzinga)
18.07.24	Pfizer, Cisco, Arch Capital And More: CNBC's 'Final Trades' (Benzinga)
17.07.24	Pfizer And Roche Advance On Their Weight Loss Drug Journeys (Benzinga)
12.07.24	With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs (Benzinga)
12.07.24	Pfizer, L3Harris Technologies And More: CNBC's 'Final Trades' (Benzinga)
11.07.24	Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition (Benzinga)
11.07.24	Why Pfizer Stock Is Moving Higher on Thursday (Benzinga)
11.07.24	Erster Studie abgebrochen: Pfizer gibt Abnehmpille nicht auf - Neuer Versuch mit Danuglipron (N-TV)
11.07.24	Pharmariese: Pfizer treibt Entwicklung von Abnehmpille voran - Aktie steigt deutlich (Handelsblatt)
11.07.24	Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market (Benzinga)
11.07.24	Pfizer signals progress on obesity pill, boosting stock (MarketWatch)
11.07.24	Pfizer pins hopes on daily pill to crack market for weight-loss drugs (Financial Times)
11.07.24	Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron (Businesswire)
10.07.24	Pfizer And Mainz Provide Examples Of Using Emerging Technology For Good (Benzinga)
09.07.24	Pfizer Launches Process To Identify Chief Scientific Officer Successor (Benzinga)
09.07.24	Pfizer Options Trading: A Deep Dive into Market Sentiment (Benzinga)
09.07.24	Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development (Businesswire)
08.07.24	Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock (MotleyFool)
08.07.24	Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip? (MotleyFool)
03.07.24	What the Options Market Tells Us About Pfizer (Benzinga)
02.07.24	London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents (Benzinga)
01.07.24	A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts (Benzinga)
01.07.24	Cyrus Taraporevala Elected to Pfizer’s Board of Directors (Businesswire)
28.06.24	This Is What Whales Are Betting On Pfizer (Benzinga)
28.06.24	Is Pfizer Stock a Buy? (MotleyFool)
27.06.24	This Recent FDA Approval Is Bad News for Pfizer (MotleyFool)
27.06.24	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten